{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T17:09:51Z","timestamp":1770224991146,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:00:00Z","timestamp":1574467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:00:00Z","timestamp":1574467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10067-019-04840-7","type":"journal-article","created":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T21:02:21Z","timestamp":1574542941000},"page":"291-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Zoledronic acid in nine patients with transient osteoporosis of the hip"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3822-3093","authenticated-orcid":false,"given":"Gerasimos","family":"Evangelatos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George E.","family":"Fragoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexios","family":"Iliopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,23]]},"reference":[{"key":"4840_CR1","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s00198-017-3952-0","volume":"28","author":"K Asadipooya","year":"2017","unstructured":"Asadipooya K, Graves L, Greene LW (2017) Transient osteoporosis of the hip: review of the literature. Osteoporos Int 28:1805\u20131816. https:\/\/doi.org\/10.1007\/s00198-017-3952-0","journal-title":"Osteoporos Int"},{"key":"4840_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/rheumatology\/ket324","volume":"53","author":"S Patel","year":"2014","unstructured":"Patel S (2014) Primary bone marrow oedema syndromes. Rheumatology (Oxford) 53:785\u2013792. https:\/\/doi.org\/10.1093\/rheumatology\/ket324","journal-title":"Rheumatology (Oxford)"},{"key":"4840_CR3","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1007\/s10067-016-3228-7","volume":"35","author":"C Trevisan","year":"2016","unstructured":"Trevisan C, Klumpp R, Compagnoni R (2016) Risk factors in transient osteoporosis: a retrospective study on 23 cases. Clin Rheumatol 35:2517\u20132522. https:\/\/doi.org\/10.1007\/s10067-016-3228-7","journal-title":"Clin Rheumatol"},{"key":"4840_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1177\/1938640015609986","volume":"9","author":"D Singh","year":"2016","unstructured":"Singh D, Ferrero A, Rose B, Goldberg A, Cullen N (2016) Bone marrow edema syndrome of the foot and ankle: mid- to long-term follow-up in 18 patients. Foot Ankle Spec 9:218\u2013226. https:\/\/doi.org\/10.1177\/1938640015609986","journal-title":"Foot Ankle Spec"},{"key":"4840_CR5","doi-asserted-by":"publisher","unstructured":"Evangelatos G, Fragoulis GE, Zampeli E, Kechagia M, Iliopoulos A (2019) Zoledronic acid is effective and safe in migratory osteoporosis. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/kez345","DOI":"10.1093\/rheumatology\/kez345"},{"key":"4840_CR6","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s10067-012-2060-y","volume":"31","author":"Y Emad","year":"2012","unstructured":"Emad Y, Ragab Y, El-Shaarawy N, Rasker JJ (2012) Transient osteoporosis of the hip, complete resolution after treatment with alendronate as observed by MRI description of eight cases and review of the literature. Clin Rheumatol 31:1641\u20131647. https:\/\/doi.org\/10.1007\/s10067-012-2060-y","journal-title":"Clin Rheumatol"},{"key":"4840_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/15360288.2016.1276993","volume":"31","author":"BJ Flores-Robles","year":"2017","unstructured":"Flores-Robles BJ, Sanz-Sanz J, Sanabria-Sanchinel AA, Huntley-Pascual D, Andreu Sanchez JL, Campos Esteban J, Blanco R, Merino-Argumanez C, Espinosa-Malpartida M, Ramos-Giraldez MC, Godoy-Tundidor H, Jimenez-Palop MM, Barbadillo Mateos C, Villa-Alcazar LF, Isasi CM, Mulero JB (2017) Zoledronic acid treatment in primary bone marrow edema syndrome. J Pain Palliat Care Pharmacother 31:52\u201356. https:\/\/doi.org\/10.1080\/15360288.2016.1276993","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"4840_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S8756-3282(02)00812-8","volume":"31","author":"M Varenna","year":"2002","unstructured":"Varenna M, Zucchi F, Binelli L, Failoni S, Gallazzi M, Sinigaglia L (2002) Intravenous pamidronate in the treatment of transient osteoporosis of the hip. Bone 31:96\u2013101","journal-title":"Bone"},{"key":"4840_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10067-007-0766-z","volume":"27","author":"L Kibbi","year":"2008","unstructured":"Kibbi L, Touma Z, Khoury N, Arayssi T (2008) Oral bisphosphonates in treatment of transient osteoporosis. Clin Rheumatol 27:529\u2013532. https:\/\/doi.org\/10.1007\/s10067-007-0766-z","journal-title":"Clin Rheumatol"},{"issue":"7","key":"4840_CR10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.4158\/EP-2018-0626","volume":"25","author":"Anupam Kotwal","year":"2019","unstructured":"Kotwal A, Hurtado MD, Sfeir JG, Wermers RA (2019) Transient osteoporosis: clinical spectrum in adults and associated risk factors. Endocr Pract. https:\/\/doi.org\/10.4158\/EP-2018-0626","journal-title":"Endocrine Practice"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04840-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04840-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04840-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T00:23:56Z","timestamp":1606004636000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04840-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,23]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["4840"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04840-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,23]]},"assertion":[{"value":"8 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}